Topic

Blue Cross Blue Shield (BCBS Association)

A collection of 1330 issues

How to Get Bavencio (Avelumab) Covered by Blue Cross Blue Shield in North Carolina: Complete Appeals Guide with Forms and Timelines

Answer Box: Getting Bavencio Covered by Blue Cross Blue Shield in North Carolina Bavencio (avelumab) requires prior authorization from Blue Cross Blue Shield of North Carolina for both Merkel cell carcinoma and urothelial carcinoma. Submit clinical documentation through the Blue Cross NC provider portal before treatment. If denied, you have

Myths vs. Facts: Getting Retevmo (selpercatinib) Covered by Blue Cross Blue Shield in California

Answer Box: Getting Retevmo Covered by Blue Cross Blue Shield California Myth: If your doctor prescribes Retevmo, Blue Cross Blue Shield must cover it. Fact: Prior authorization is required with specific RET alteration testing documentation. Fastest path: Submit PA with RNA-based NGS results showing RET fusion/mutation, prior therapy records,

How to Get Skyrizi (Risankizumab) Covered by Blue Cross Blue Shield of Illinois: Complete Prior Authorization and Appeals Guide

Quick Answer: Blue Cross Blue Shield of Illinois requires prior authorization for Skyrizi (risankizumab). Submit the Illinois Uniform PA Form through Prime Therapeutics with documented step therapy attempts. If denied, you have 180 days to appeal internally, then 4 months for Illinois external review. Start by calling the number on

How to Get Ilaris (Canakinumab) Covered by Blue Cross Blue Shield in California: Complete Prior Authorization and Appeal Guide

Quick Answer: Blue Cross Blue Shield California requires prior authorization for Ilaris (canakinumab) for Still's disease and SJIA. Submit PA request with rheumatologist prescription, weight-based dosing documentation, and diagnosis codes (M06.1 for AOSD, M08.2X for SJIA). If denied, California's Independent Medical Review has a

Get Defitelio (Defibrotide) Covered by Blue Cross Blue Shield in North Carolina: Appeals Guide and Alternative Options

Answer Box: Getting Defitelio Covered by Blue Cross Blue Shield in North Carolina Defitelio (defibrotide) is not listed on Blue Cross Blue Shield of North Carolina's standard formularies and requires prior authorization for hepatic veno-occlusive disease (VOD/SOS) post-transplant. Success path: Submit PA through provider portal with complete

Get Luxturna Covered by Blue Cross Blue Shield in New York: Complete Provider Partnership Guide

Answer Box: Getting Luxturna Covered by Blue Cross Blue Shield in New York Eligibility: Confirmed biallelic RPE65 mutations + viable retinal cells (>100 microns thickness) + treatment at qualified center. Fastest path: Partner with your retinal specialist to submit comprehensive prior authorization with genetic test results, OCT scans, and medical necessity

Do You Qualify for Emgality Coverage by Blue Cross Blue Shield in Texas? Decision Tree & Next Steps

Answer Box: Getting Emgality Covered in Texas Blue Cross Blue Shield of Texas requires prior authorization for Emgality (galcanezumab-gnlm). Most patients qualify if they have chronic or episodic migraine, have failed 2+ standard preventive medications, and can document migraine frequency with a headache diary. The fastest path: Have your neurologist

How to Get Evkeeza (Evinacumab) Covered by Blue Cross Blue Shield in Virginia: Complete PA Guide and Appeals Process

Answer Box: Getting Evkeeza Covered by Blue Cross Blue Shield in Virginia Evkeeza (evinacumab) requires prior authorization from all Blue Cross Blue Shield plans in Virginia. For fastest approval: (1) Confirm HoFH diagnosis with genetic testing or clinical criteria, (2) Document maximum tolerated lipid-lowering therapy (statin + ezetimibe + PCSK9 inhibitor), and

How to Get Raxone (Idebenone) Covered by Blue Cross Blue Shield in Florida: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Raxone Covered by Florida Blue Cross Blue Shield Quick Answer: Raxone (idebenone) requires prior authorization from Florida Blue Cross Blue Shield for LHON treatment. Since it's not FDA-approved in the US, coverage depends on comprehensive medical necessity documentation including genetic LHON confirmation, failed alternatives, and

How to Get Koselugo (Selumetinib) Covered by Blue Cross Blue Shield in Florida: Complete Guide to Prior Authorization, Appeals, and Approval Success

Quick Answer: Getting Koselugo Covered by Florida Blue Cross Blue Shield Koselugo (selumetinib) is covered by Florida Blue Cross Blue Shield for pediatric patients (≥2 years) with NF1 and symptomatic, inoperable plexiform neurofibromas. Coverage requires prior authorization with specific documentation: confirmed NF1 diagnosis, baseline cardiac (LVEF) and eye exams, and